Targeted diet and exercise intervention could improve chemotherapy outcomes for breast cancer patients

A new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer.

CRISPR gene therapy Casgevy secures approval in Europe – Pharmaceutical Technology

Share this article Casgevy is already approved for sickle cell disease and TDT in the US and UK. Image credit: Shutterstock/LadadikArt. Vertex Pharmaceuticals and CRISPR

February 13, 2024

Pioneering Entry into the High-Growth Medical Aesthetics Market – Biotech Investments

EQS Newswire / 02/12/2024 / 18:14 UTC+8 2nd December 2024 –Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the

December 3, 2024

M&A activity in the pharmaceutical industry in Brazil decreased in 2023

In value terms, M&A activity in Brazil increased by 751% in Q2 2023 compared with the previous quarter’s total of $41.1m and fell by 29%

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.